The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Johnson & Johnson to acquire Momenta for $52.50 per share in cash, representing a total equity value of $6.5 billion and a 70% premium to Momenta’s closing price on August 18, 2020 Momenta’s FcRn ...

The deal values Momenta at $52.50 per share, a 70.4% premium to its Wednesday close. The deal is expected to close in the ...

Johnson & Johnson’s $6.5 billion takeover of Momenta Pharmaceuticals came out of the blue last month. Yet, behind the scenes, the companies had been circling each other for more than 18 months, ...

With sales of Momenta Pharmaceuticals' (NASDAQ: MNTA) generic drugs failing to cover expenses, the biotech's earnings releases have focused on its pipeline of novel drugs, which will take a few years ...

SHANGHAI/BERLIN (Reuters) -Mercedes-Benz is betting on China's Momenta to help it win back market share in the world's biggest auto market, with plans for fresh investment and at least four future ...

It's fairly common for shares to drop after the announcement of a secondary offering. Current shareholders will be diluted when the additional shares are issued, resulting in each share representing a ...

-- Reported favorable interim data from Phase 1/2 study of M254 in ITP, supporting expansion of Part B; expect to report updated data in Q2 2020 and launch additional Phase 2 study in CIDP in Q4 2020 ...

Uber Technologies, Inc. (NYSE:UBER) and Momenta on Monday announced plans to test Level 4 autonomous vehicles in Germany next year. The collaboration will integrate Momenta’s advanced, AI-driven ...

Momenta recorded $6.6 million in product revenue from sales of Novartis' Glatopa, a generic version of multiple sclerosis treatment Copaxone. That was double the same period a year ago, but nothing to ...